Lifeward (LFWD) Share-based Compensation Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -19.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.55% |
| Dec 31, 2025 | -28.63% |
| Sep 30, 2025 | -40.00% |
| Jun 30, 2025 | -51.60% |
| Mar 31, 2025 | -42.26% |
| Dec 31, 2024 | -37.27% |
| Sep 30, 2024 | -12.91% |
| Jun 30, 2024 | 18.24% |
| Mar 31, 2024 | 25.33% |
| Dec 31, 2023 | 7.49% |
| Sep 30, 2023 | 4.06% |
| Jun 30, 2023 | 83.82% |
| Mar 31, 2023 | 98.69% |
| Dec 31, 2022 | 48.29% |
| Sep 30, 2022 | 38.53% |
| Jun 30, 2022 | -13.50% |
| Mar 31, 2022 | -8.93% |
| Dec 31, 2021 | 14.15% |
| Sep 30, 2021 | -0.43% |
| Jun 30, 2021 | 76.99% |
| Mar 31, 2021 | -15.58% |
| Dec 31, 2020 | -14.23% |
| Sep 30, 2020 | -1.69% |
| Jun 30, 2020 | -64.01% |
| Mar 31, 2020 | -37.62% |
| Dec 31, 2019 | -43.63% |
| Sep 30, 2019 | -54.88% |
| Jun 30, 2019 | -69.31% |
| Mar 31, 2019 | -59.92% |
| Dec 31, 2018 | -59.89% |
| Sep 30, 2018 | -41.82% |
| Jun 30, 2018 | 20.78% |
| Mar 31, 2018 | -6.46% |
| Dec 31, 2017 | 12.45% |
| Sep 30, 2017 | -1.75% |
| Jun 30, 2017 | 2.54% |
| Mar 31, 2017 | 18.69% |
| Dec 31, 2016 | 42.21% |
| Sep 30, 2016 | 78.36% |
| Jun 30, 2016 | 41.20% |
| Mar 31, 2016 | 22.35% |
| Dec 31, 2015 | 128.72% |
| Dec 31, 2014 | 295.89% |